HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N- (4- morpholine)carbonyl- beta- (1- naphthyl)- alanyl- leucine boronic acid
a proteasome inhibitor
Also Known As:
MLN 273; MLN-273; MLN273; N-(4-morpholine)carbonyl-beta-(1-naphthyl)-L-alanyl-L-leucine boronic acid
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Inorganic Chemicals: 9
Acids: 53217
Noncarboxylic Acids
Boronic Acids: 200
N-(4-morpholine)carbonyl-beta-(1-naphthyl)-alanyl-leucine boronic acid: 1
Boron Compounds: 91
Boronic Acids: 200
N-(4-morpholine)carbonyl-beta-(1-naphthyl)-alanyl-leucine boronic acid: 1
Organic Chemicals: 133
Boron Compounds: 91
Boronic Acids: 200
N-(4-morpholine)carbonyl-beta-(1-naphthyl)-alanyl-leucine boronic acid: 1
Amino Acids, Peptides, and Proteins: 1
Peptides: 82426
Oligopeptides: 519
Dipeptides: 945
N-(4-morpholine)carbonyl-beta-(1-naphthyl)-alanyl-leucine boronic acid: 1
Experts
1.
Gastl, Guenther
: 1 article (09/2007)
2.
Rumpold, Holger
: 1 article (09/2007)
3.
Salvador, Christina
: 1 article (09/2007)
4.
Tilg, Herbert
: 1 article (09/2007)
5.
Wolf, Anna Maria
: 1 article (09/2007)
6.
Wolf, Dominik
: 1 article (09/2007)
Related Diseases
1.
Neoplasms (Cancer)
09/21/2007 - "
Our report provides evidence that MLN273 and, to a lesser degree, Bortezomib are both MDR-1-substrates, which might be relevant for drug-resistance in cancer.
"
Related Drugs and Biologics
1.
Bortezomib (Velcade)